Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001707723 | SCV000620818 | uncertain significance | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | Has not been reported in peer-reviewed literature to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27535533, Liu2015[meetingabstract]) |
Fulgent Genetics, |
RCV002490919 | SCV002778309 | uncertain significance | Brittle cornea syndrome 1 | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003403240 | SCV004105409 | uncertain significance | ZNF469-related disorder | 2023-09-08 | criteria provided, single submitter | clinical testing | The ZNF469 c.585C>G variant is predicted to result in the amino acid substitution p.Asn195Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0071% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-88494463-C-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |